IVTEAM the online citation library and resource center for vascular access and intravenous infusion therapy professionals. Thousands of citations to search. New content added daily. We take the strain out of literature searching.
Recent from IVTEAM
Access Scientific unveils partnership with Smiths Medical to sell Access’ POWERWAND product lines
To expand marketing and sales of POWERWAND in association with the Smiths Medical relationship, Access Scientific has secured $20M in additional capital funding from existing
Skin colonization at peripheral intravenous catheter insertion sites
In this study, the impact of PIVC skin site colonization on tip colonization and the development of CRBSI was investigated” Choudhury et al (2019). Abstract:
Implantable port placement in patients at risk of lymphedema
There was no difference in port complications or lymphedema rates between patients who had ports placed on the ipsilateral side compared with the contralateral side
Report of PICC embolization following surgical procedure
In this report, we describe a rare scenario of catheter breakage, entrapment, and embolization in a patient caused by inadvertent surgical clip and suture placement”
Evaluation of implanted venous ports in children with complex needs
To analyze the use of implanted port-a-caths in children with medical complexity who have neurologic impairment and difficult venous access” Pezeshkpour et al (2019). Abstract:
Augmented ultrasound technique for central venous cannulation
Two-dimensional ultrasound (2DUS) guidance for central venous cannulation is a best-practice for patient safety identified by the Agency for Healthcare Research and Quality and the
BD recalls Alaris Infusion Sets for the Alaris Pump Model 8100
Becton Dickinson (BD) is recalling Alaris Infusion Sets, due to the potential for faster than expected delivery of medication (over-infusion) or an unintended delivery that
BD recalls Alaris pump module model 8100 bezel assembly due to free flow risk
This product was initially recalled on August 9, 2017 (FDA Recall # Z-0026-2018). The firm subsequently expanded the recall on April 13, 2018 to expand
Analysis of insurance claims from central venous access injuries
The aim was to analyse injuries reported to the Swedish National Patient Insurance Company (Löf) within 7 days after insertion or removal of a CVAD”
Loss of guidewire and its sequelae after central venous catheterization
Here, we report a peculiar case of a missed guidewire puncturing the aortic arch and cerebrum” Zhao et al (2019). Abstract: RATIONALE: Central venous catheterization
Implementation of second-tier prevention practices and CLABSI rates
Implementation of second-tier preventive practices was protective against CLABSI. Use of more practices was correlated with lower rates” Ben-David et al (2019). Abstract: BACKGROUND: Prevention
Etiology and management of upper-extremity catheter-related thrombosis
Catheter-related thrombosis (CRT) is a common complication of central venous access devices in oncology patients. Risk factors for CRT include patient-, device-, and treatment-related risk